Home › NDC Lookup › RxCUI directory › RxCUI 2572292

0.4 ML cyclosporine 0.5 MG/ML Ophthalmic Suspension — RxCUI 2572292

RxNorm drug concept · Semantic clinical drug
RxCUI 2572292 Semantic clinical drug · SCD ● Current RxNorm concept 11 FDA products 22 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2572292
Official name0.4 ML cyclosporine 0.5 MG/ML Ophthalmic Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascyclosporine 0.05 % per 0.4 ML Ophthalmic Emulsion; cycloSPORINE 0.05 % in 0.4 ML Ophthalmic Emulsion; cyclosporine 0.5 MG/ML per 0.4 ML Ophthalmic Emulsion
FDA products mapped11
Package NDCs mapped22
Reported Medicaid activity (SDUD)328,030 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Cyclosporine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on the product. Oral forms help prevent organ rejection after kidney, liver or heart transplants. Some oral products also treat severe rheumatoid arthritis and severe pl...
  • Oral modified forms like Neoral and Gengraf are taken twice a day. Keep your timing and meal routine consistent from day to day. Follow your prescriber's directions and the label.
  • No, avoid grapefruit and grapefruit juice. They raise cyclosporine levels in your blood, which can increase side effects.
  • Not on your own. Modified products such as Neoral and Gengraf are not interchangeable with Sandimmune, and switching needs your doctor's supervision and extra blood level checks.
📖 Read our full Cyclosporine guide →

🕸️ Concept Web — How 0.4 ML cyclosporine 0.5 MG/ML Ophthalmic Suspens... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 0.4 ML cyclosporine 0.5 MG/ML Ophthalmic Suspension RxCUI 2572292

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Cyclosporine 3008
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Restasis 352951
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Cyclosporine Ophthalmic Suspension 378766
    • Cyclosporine Ophthalmic Product 1156187
    • Cyclosporine Ophthalmic Suspension [Restasis] 402330
    • Restasis Ophthalmic Product 1182527
    • Ophthalmic Suspension 316964
    • Ophthalmic Product 1151135
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Cyclosporine 0.5 MG/ML SCDC · 353400
  • Cyclosporine Ophthalmic Suspension SCDF · 378766
  • Cyclosporine Ophthalmic Product SCDG · 1156187

Brand-Name Concepts

📦 FDA Products & Package NDCs

11 products · 22 package NDCs
22 package NDCs map to RxCUI 2572292 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00023-9163-12 5 VIAL, SINGLE-USE in 1 CARTON (0023-9163-12) / .4 mL in 1... RESTASIS Allergan, Inc. 2003-04-01
00023-9163-30 30 VIAL, SINGLE-USE in 1 TRAY (0023-9163-30) / .4 mL in 1 V... RESTASIS Allergan, Inc. 2003-04-01
00023-9163-60 60 VIAL, SINGLE-USE in 1 TRAY (0023-9163-60) / .4 mL in 1 V... RESTASIS Allergan, Inc. 2003-04-01
00378-8760-58 6 POUCH in 1 CARTON (0378-8760-58) / 5 VIAL, SINGLE-USE in... Cyclosporine Mylan Pharmaceuticals Inc. 2022-02-03
00378-8760-91 12 POUCH in 1 CARTON (0378-8760-91) / 5 VIAL, SINGLE-USE in... Cyclosporine Mylan Pharmaceuticals Inc. 2022-02-03
00480-4076-30 6 POUCH in 1 CARTON (0480-4076-30) / 5 VIAL, SINGLE-DOSE in... Cyclosporine Teva Pharmaceuticals, Inc. 2025-10-28
00480-4076-60 12 POUCH in 1 CARTON (0480-4076-60) / 5 VIAL, SINGLE-DOSE i... Cyclosporine Teva Pharmaceuticals, Inc. 2025-10-28
10702-0808-03 30 VIAL, SINGLE-USE in 1 TRAY (10702-808-03) / .4 mL in 1 V... Cyclosporine KVK-TECH, INC. 2022-02-10
10702-0808-06 60 VIAL, SINGLE-USE in 1 TRAY (10702-808-06) / .4 mL in 1 V... Cyclosporine KVK-TECH, INC. 2022-02-10
24979-0126-18 60 VIAL, SINGLE-USE in 1 CARTON (24979-126-18) / .4 mL in 1... CYCLOSPORINE Upsher-Smith Laboratories, LLC 2026-03-27
24979-0126-19 30 VIAL, SINGLE-USE in 1 CARTON (24979-126-19) / .4 mL in 1... CYCLOSPORINE Upsher-Smith Laboratories, LLC 2026-03-27
50090-4476-00 30 VIAL, SINGLE-USE in 1 TRAY (50090-4476-0) / .4 mL in 1 V... RESTASIS A-S Medication Solutions 2019-08-26
60505-6202-01 30 VIAL in 1 TRAY (60505-6202-1) / .4 mL in 1 VIAL Cyclosporine Apotex Corp 2022-02-07
60505-6202-02 60 VIAL in 1 TRAY (60505-6202-2) / .4 mL in 1 VIAL Cyclosporine Apotex Corp 2022-02-07
68180-0214-30 30 VIAL, SINGLE-USE in 1 TRAY (68180-214-30) / .4 mL in 1 V... CYCLOSPORINE Lupin Pharmaceuticals, Inc. 2022-05-11
68180-0214-60 60 VIAL, SINGLE-USE in 1 TRAY (68180-214-60) / .4 mL in 1 V... CYCLOSPORINE Lupin Pharmaceuticals, Inc. 2022-05-11
69238-1023-03 3 POUCH in 1 CARTON (69238-1023-3) / 10 VIAL, SINGLE-USE in... Cyclosporine Amneal Pharmaceuticals NY LLC 2025-12-01
69238-1023-06 6 POUCH in 1 CARTON (69238-1023-6) / 10 VIAL, SINGLE-USE in... Cyclosporine Amneal Pharmaceuticals NY LLC 2025-12-01
71656-0012-30 6 POUCH in 1 CARTON (71656-012-30) / 5 VIAL, SINGLE-DOSE in... CYCLOSPORINE Saptalis Pharmaceuticals, LLC 2025-12-12
71656-0012-60 12 POUCH in 1 CARTON (71656-012-60) / 5 VIAL, SINGLE-DOSE i... CYCLOSPORINE Saptalis Pharmaceuticals, LLC 2025-12-12
73043-0005-01 3 POUCH in 1 CARTON (73043-005-01) / 10 VIAL, SINGLE-USE in... Cyclosporine Devatis Inc. 2024-07-04
73043-0005-02 6 POUCH in 1 CARTON (73043-005-02) / 10 VIAL, SINGLE-USE in... Cyclosporine Devatis Inc. 2024-07-04
Observed labelers: Allergan, Inc. (3) · Amneal Pharmaceuticals NY LLC (2) · Apotex Corp (2) · Devatis Inc. (2) · KVK-TECH, INC. (2) · Lupin Pharmaceuticals, Inc. (2) · +5 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$1.3197
Range $1.0833–$10.3179 · middle 50% $1.0833–$1.3197 · 16 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.